Spots Global Cancer Trial Database for Registry Platform Urologic Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Registry Platform Urologic Cancer
Official Title: Clinical Research Platform On Urologic Cancer Treatment And Outcome (Registry Platform Urologic Cancer; CARAT)
Study ID: NCT03374267
Interventions
Study Description
Brief Summary: The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with advanced renal cell carcinoma or advanced urothelial cancer in Germany.
Detailed Description: CARAT is a national, observational, prospective, longitudinal, multicenter cohort study (tumor registry platform) with the purpose to record information on the antineoplastic treatment of renal cell carcinoma and urothelial cancer in Germany. The registry will follow patients with advanced renal carcinoma for up to three years, and patients with advanced urothelial cancer for up to two years. It will identify common therapeutic sequences and changes in the treatment of the disease. At inclusion, data in patient characteristics, comorbidities, tumor characteristics and previous treatments are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and outcome are documented. Health-related quality of life (HRQoL) in patients with renal cell carcinoma or urothelial cancel will be evaluated for up to two years.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Multiple sites, Germany, Multiple Locations, , Germany
Contact Details
Name: Michael Staehler, Prof. Dr.
Affiliation: Urologische Klinik und Poliklinik, Klinikum der Universität München
Role: STUDY_CHAIR
Name: Peter Goebell, Prof. Dr.
Affiliation: Urologische Universitätsklinik, Waldkrankenhaus St. Marien
Role: STUDY_CHAIR
Name: Lothar Müller, Dr.
Affiliation: Onkologie Leer - Emden - Papenburg
Role: STUDY_CHAIR
Name: Viktor Grünwald, Prof. Dr.
Affiliation: Universitätsklinikum Essen (AöR), Westdeutsches Tumorzentrum Essen
Role: STUDY_CHAIR
Name: Carsten Grüllich, Prof. Dr.
Affiliation: Caritas Krankenhaus, Lebach
Role: STUDY_CHAIR
Name: Christian Gratzke, Prof. Dr.
Affiliation: Universitätsklinikum Freiburg Urologie
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
